Estimates Revisions PYC Therapeutics Limited
Stocks
PYC
AU000000PYC7
Biotechnology & Medical Research
|
Market Closed -
Australian S.E.
10:20:43 18/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.670 AUD | +11.25% |
|
+15.09% | +61.33% |
| 09-11 | PYC Therapeutics Says First Patient Dosed in Open-Label Extension of Drug Candidate Study in Polycystic Kidney Disease | MT |
| 09-04 | PYC Therapeutics Limited - Special Call |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- PYC Stock
- Consensus PYC Therapeutics Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
